IL4R and IL13 polymorphic variants and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to HBV vaccination or infection

Vaccine

Volumn 31, Issue 14, 2013, Pages 1766-1770

  Grzegorzewska, Alicja E ^a   Pajzderski, Dominik ^a   Sowińska, Anna ^a   Mostowska, Adrianna ^a   Jagodziński, Paweł P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Anti HBs; HBV infection; Hemodialysis; IL13; IL4R; Vaccination

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; HEPAVAX; INTERLEUKIN 13; INTERLEUKIN 4 RECEPTOR; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; VACCINATION;

ANTIGENS, SURFACE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INTERLEUKIN-13; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-4; RENAL DIALYSIS;

EID: 84875268446     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.02.023     Document Type: Article

References (20)

1. Lin Y.J., Lan Y.C., Huang Y.C., Lin T.H., Huang S.M., Lai C.C., et al. Effects of cytokine and cytokine receptor gene variation on high anti-HB titers: following up on Taiwan's neonatal hepatitis B immunization program. Clin Chim Acta 2012, 413:1194-1198.
2. Wang C., Tang J., Song W., Lobashevsky E., Wilson C.M., Kaslow R.A. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 2004, 39:978-988.
3. Girndt M., Sester U., Sester M., Deman E., Ulrich C., Kaul H., et al. The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients. Kidney Int 2001, 60:2385-2391.
4. Höhler T., Reuss E., Freitag C.M., Schneider P.M. A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A. Hepatology 2005, 42:72-76.
5. Yucesoy B., Sleijffers A., Kashon M., Garssen J., de Gruijl F.R., Boland G.J., et al. IL-1beta gene polymorphisms influence hepatitis B vaccination. Vaccine 2002, 20:3193-3196.
6. Chen J., Liang Z., Lu F., Fang X., Liu S., Zeng Y., et al. Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine. Vaccine 2011, 29:706-711.
7. Sleijffers A., Yucesoy B., Kashon M., Garssen J., De Gruijl F.R., Boland G.J., et al. Cytokine polymorphisms play a role in susceptibility to ultraviolet B-induced modulation of immune responses after hepatitis B vaccination. J Immunol 2003, 170:3423-3428.
8. Grzegorzewska A.E., Wobszal P.M., Mostowska A., Jagodzinski P.P. Antibodies to hepatitis B virus surface antigen and interleukin 12 and interleukin 18 gene polymorphisms in hemodialysis patients. BMC Nephrol 2012, 13:75. 10.1186/1471-2369-13-75.
9. Hennig B.J., Fielding K., Broxholme J., Diatta M., Mendy M., Moore C., et al. Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. PLoS ONE 2008, 3:e1898.
10. Grzegorzewska A.E., Wobszal P., Jagodzinski P.P. Interleukin-18 promoter polymorphism and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients. Kidney Blood Press Res 2012, 35:1-8.
11. Wynn T.A. IL-13 effector functions. Annu Rev Immunol 2003, 21:425-456.
12. Sui W., Tan J., Guo J., Du G., Dai Y. An altered TH1/TH2 and pro-inflammatory cytokine profile in patients with end-stage renal disease detected by suspension array technology. Ren Fail 2009, 31:1-5.
13. U.S.Department of Health and Human Services.Centers for Disease Control and Prevention Recommendations for preventing transmission of infections among chronic hemodialysis patients. Morbidity and Mortality Weekly Report 2001, 50:RR-5.
14. Zała{ogonek}czniki do rozporza{ogonek}dzenia Ministra Zdrowia z dnia 18 kwietnia 2005 r.
15. Mosmann T.R., Coffman R.L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989, 46:111-147.
16. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793.
17. Wang L., Lin S.J., Tsai J.H., Tsai C.H., Tsai C.C., Yang C.C. Anti-hepatitis B surface antigen IgG1 subclass is predominant in individuals who have recovered from hepatitis B virus infection, chronic carriers and vaccinees. Med Microbiol Immunol 2005, 194:33-38.
18. Grzegorzewska A.E., Wobszal P., Mostowska A., Jagodziński P.P. Association of IL12 polymorphic variants with development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to hepatitis B virus vaccination or infection. Abstr. SAP603. 49th ERA-EDTA Congr., Paryż, 24-27.05.2012. Nephrol Dial Transplant 2012;27:ii513.
19. Fabrizi F., Dixit V., Martin P., Messa P. Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients. Aliment Pharmacol Ther 2011, 33:815-821.
20. Shatat H.Z., Kotkat A.M., Farghaly A.G. Immune response to hepatitis B vaccine in haemodialysis patients. J Egypt Public Health Assoc 2000, 75:257-275.